ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceuticals and Biotechnology R & D Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-15Z7791
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceuticals and Biotechnology R D Market Insights Forecast to 2028
BUY CHAPTERS

Global Pharmaceuticals and Biotechnology R & D Market Research Report 2025

Code: QYRE-Auto-15Z7791
Report
July 2025
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Johnson & Johnson
Merck
Novartis
Pfizer Inc
Sanofi
Bayer
Bristol–Myers Squibb
Astrazeneca plc
GlaxoSmithKline PLC
AbbVie
Eli Lilly
BOEHRINGER SOHN
Amgen Inc
Gilead Sciences
Takeda Pharmaceutical
Novo Nordisk
Biogen
Abbott
Astellas Pharma
Teva Pharmaceutical Industries

Pharmaceuticals and Biotechnology R & D Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharmaceuticals and Biotechnology R & D Market

Pharmaceuticals and Biotechnology R & D Market

The global market for Pharmaceuticals and Biotechnology R & D was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceuticals and Biotechnology R & D, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceuticals and Biotechnology R & D.
The Pharmaceuticals and Biotechnology R & D market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceuticals and Biotechnology R & D market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceuticals and Biotechnology R & D companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmaceuticals and Biotechnology R & D Market Report

Report Metric Details
Report Name Pharmaceuticals and Biotechnology R & D Market
CAGR 5%
Segment by Type
  • Drug
  • Medical Equipment
  • Vaccine
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Homecare
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ROCHE, JOHNSON & JOHNSON, MERCK, NOVARTIS, PFIZER, SANOFI, BAYER, BRISTOL-MYERS SQUIBB, ASTRAZENECA, GLAXOSMITHKLINE, ABBVIE, ELI LILLY, BOEHRINGER SOHN, AMGEN, GILEAD SCIENCES, TAKEDA PHARMACEUTICAL, NOVO NORDISK, BIOGEN, ABBOTT, ASTELLAS PHARMA, TEVA PHARMACEUTICAL INDUSTRIES
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmaceuticals and Biotechnology R & D company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceuticals and Biotechnology R & D Market report?

Ans: The main players in the Pharmaceuticals and Biotechnology R & D Market are ROCHE, JOHNSON & JOHNSON, MERCK, NOVARTIS, PFIZER, SANOFI, BAYER, BRISTOL-MYERS SQUIBB, ASTRAZENECA, GLAXOSMITHKLINE, ABBVIE, ELI LILLY, BOEHRINGER SOHN, AMGEN, GILEAD SCIENCES, TAKEDA PHARMACEUTICAL, NOVO NORDISK, BIOGEN, ABBOTT, ASTELLAS PHARMA, TEVA PHARMACEUTICAL INDUSTRIES

What are the Application segmentation covered in the Pharmaceuticals and Biotechnology R & D Market report?

Ans: The Applications covered in the Pharmaceuticals and Biotechnology R & D Market report are Hospital, Clinic, Homecare, Others

What are the Type segmentation covered in the Pharmaceuticals and Biotechnology R & D Market report?

Ans: The Types covered in the Pharmaceuticals and Biotechnology R & D Market report are Drug, Medical Equipment, Vaccine, Others

Recommended Reports

Drug Discovery & Delivery

Diagnostics & Testing

Therapeutics & Vaccines

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceuticals and Biotechnology R & D Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drug
1.2.3 Medical Equipment
1.2.4 Vaccine
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharmaceuticals and Biotechnology R & D Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Homecare
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceuticals and Biotechnology R & D Market Perspective (2020-2031)
2.2 Global Pharmaceuticals and Biotechnology R & D Growth Trends by Region
2.2.1 Global Pharmaceuticals and Biotechnology R & D Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceuticals and Biotechnology R & D Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceuticals and Biotechnology R & D Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceuticals and Biotechnology R & D Market Dynamics
2.3.1 Pharmaceuticals and Biotechnology R & D Industry Trends
2.3.2 Pharmaceuticals and Biotechnology R & D Market Drivers
2.3.3 Pharmaceuticals and Biotechnology R & D Market Challenges
2.3.4 Pharmaceuticals and Biotechnology R & D Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceuticals and Biotechnology R & D Players by Revenue
3.1.1 Global Top Pharmaceuticals and Biotechnology R & D Players by Revenue (2020-2025)
3.1.2 Global Pharmaceuticals and Biotechnology R & D Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceuticals and Biotechnology R & D Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceuticals and Biotechnology R & D Revenue
3.4 Global Pharmaceuticals and Biotechnology R & D Market Concentration Ratio
3.4.1 Global Pharmaceuticals and Biotechnology R & D Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceuticals and Biotechnology R & D Revenue in 2024
3.5 Global Key Players of Pharmaceuticals and Biotechnology R & D Head office and Area Served
3.6 Global Key Players of Pharmaceuticals and Biotechnology R & D, Product and Application
3.7 Global Key Players of Pharmaceuticals and Biotechnology R & D, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceuticals and Biotechnology R & D Breakdown Data by Type
4.1 Global Pharmaceuticals and Biotechnology R & D Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceuticals and Biotechnology R & D Forecasted Market Size by Type (2026-2031)
5 Pharmaceuticals and Biotechnology R & D Breakdown Data by Application
5.1 Global Pharmaceuticals and Biotechnology R & D Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceuticals and Biotechnology R & D Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceuticals and Biotechnology R & D Market Size (2020-2031)
6.2 North America Pharmaceuticals and Biotechnology R & D Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceuticals and Biotechnology R & D Market Size by Country (2020-2025)
6.4 North America Pharmaceuticals and Biotechnology R & D Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceuticals and Biotechnology R & D Market Size (2020-2031)
7.2 Europe Pharmaceuticals and Biotechnology R & D Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceuticals and Biotechnology R & D Market Size by Country (2020-2025)
7.4 Europe Pharmaceuticals and Biotechnology R & D Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceuticals and Biotechnology R & D Market Size (2020-2031)
9.2 Latin America Pharmaceuticals and Biotechnology R & D Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceuticals and Biotechnology R & D Market Size by Country (2020-2025)
9.4 Latin America Pharmaceuticals and Biotechnology R & D Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ROCHE
11.1.1 ROCHE Company Details
11.1.2 ROCHE Business Overview
11.1.3 ROCHE Pharmaceuticals and Biotechnology R & D Introduction
11.1.4 ROCHE Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.1.5 ROCHE Recent Development
11.2 JOHNSON & JOHNSON
11.2.1 JOHNSON & JOHNSON Company Details
11.2.2 JOHNSON & JOHNSON Business Overview
11.2.3 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R & D Introduction
11.2.4 JOHNSON & JOHNSON Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.2.5 JOHNSON & JOHNSON Recent Development
11.3 MERCK
11.3.1 MERCK Company Details
11.3.2 MERCK Business Overview
11.3.3 MERCK Pharmaceuticals and Biotechnology R & D Introduction
11.3.4 MERCK Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.3.5 MERCK Recent Development
11.4 NOVARTIS
11.4.1 NOVARTIS Company Details
11.4.2 NOVARTIS Business Overview
11.4.3 NOVARTIS Pharmaceuticals and Biotechnology R & D Introduction
11.4.4 NOVARTIS Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.4.5 NOVARTIS Recent Development
11.5 PFIZER
11.5.1 PFIZER Company Details
11.5.2 PFIZER Business Overview
11.5.3 PFIZER Pharmaceuticals and Biotechnology R & D Introduction
11.5.4 PFIZER Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.5.5 PFIZER Recent Development
11.6 SANOFI
11.6.1 SANOFI Company Details
11.6.2 SANOFI Business Overview
11.6.3 SANOFI Pharmaceuticals and Biotechnology R & D Introduction
11.6.4 SANOFI Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.6.5 SANOFI Recent Development
11.7 BAYER
11.7.1 BAYER Company Details
11.7.2 BAYER Business Overview
11.7.3 BAYER Pharmaceuticals and Biotechnology R & D Introduction
11.7.4 BAYER Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.7.5 BAYER Recent Development
11.8 BRISTOL-MYERS SQUIBB
11.8.1 BRISTOL-MYERS SQUIBB Company Details
11.8.2 BRISTOL-MYERS SQUIBB Business Overview
11.8.3 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R & D Introduction
11.8.4 BRISTOL-MYERS SQUIBB Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.8.5 BRISTOL-MYERS SQUIBB Recent Development
11.9 ASTRAZENECA
11.9.1 ASTRAZENECA Company Details
11.9.2 ASTRAZENECA Business Overview
11.9.3 ASTRAZENECA Pharmaceuticals and Biotechnology R & D Introduction
11.9.4 ASTRAZENECA Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.9.5 ASTRAZENECA Recent Development
11.10 GLAXOSMITHKLINE
11.10.1 GLAXOSMITHKLINE Company Details
11.10.2 GLAXOSMITHKLINE Business Overview
11.10.3 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R & D Introduction
11.10.4 GLAXOSMITHKLINE Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.10.5 GLAXOSMITHKLINE Recent Development
11.11 ABBVIE
11.11.1 ABBVIE Company Details
11.11.2 ABBVIE Business Overview
11.11.3 ABBVIE Pharmaceuticals and Biotechnology R & D Introduction
11.11.4 ABBVIE Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.11.5 ABBVIE Recent Development
11.12 ELI LILLY
11.12.1 ELI LILLY Company Details
11.12.2 ELI LILLY Business Overview
11.12.3 ELI LILLY Pharmaceuticals and Biotechnology R & D Introduction
11.12.4 ELI LILLY Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.12.5 ELI LILLY Recent Development
11.13 BOEHRINGER SOHN
11.13.1 BOEHRINGER SOHN Company Details
11.13.2 BOEHRINGER SOHN Business Overview
11.13.3 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R & D Introduction
11.13.4 BOEHRINGER SOHN Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.13.5 BOEHRINGER SOHN Recent Development
11.14 AMGEN
11.14.1 AMGEN Company Details
11.14.2 AMGEN Business Overview
11.14.3 AMGEN Pharmaceuticals and Biotechnology R & D Introduction
11.14.4 AMGEN Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.14.5 AMGEN Recent Development
11.15 GILEAD SCIENCES
11.15.1 GILEAD SCIENCES Company Details
11.15.2 GILEAD SCIENCES Business Overview
11.15.3 GILEAD SCIENCES Pharmaceuticals and Biotechnology R & D Introduction
11.15.4 GILEAD SCIENCES Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.15.5 GILEAD SCIENCES Recent Development
11.16 TAKEDA PHARMACEUTICAL
11.16.1 TAKEDA PHARMACEUTICAL Company Details
11.16.2 TAKEDA PHARMACEUTICAL Business Overview
11.16.3 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R & D Introduction
11.16.4 TAKEDA PHARMACEUTICAL Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.16.5 TAKEDA PHARMACEUTICAL Recent Development
11.17 NOVO NORDISK
11.17.1 NOVO NORDISK Company Details
11.17.2 NOVO NORDISK Business Overview
11.17.3 NOVO NORDISK Pharmaceuticals and Biotechnology R & D Introduction
11.17.4 NOVO NORDISK Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.17.5 NOVO NORDISK Recent Development
11.18 BIOGEN
11.18.1 BIOGEN Company Details
11.18.2 BIOGEN Business Overview
11.18.3 BIOGEN Pharmaceuticals and Biotechnology R & D Introduction
11.18.4 BIOGEN Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.18.5 BIOGEN Recent Development
11.19 ABBOTT
11.19.1 ABBOTT Company Details
11.19.2 ABBOTT Business Overview
11.19.3 ABBOTT Pharmaceuticals and Biotechnology R & D Introduction
11.19.4 ABBOTT Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.19.5 ABBOTT Recent Development
11.20 ASTELLAS PHARMA
11.20.1 ASTELLAS PHARMA Company Details
11.20.2 ASTELLAS PHARMA Business Overview
11.20.3 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R & D Introduction
11.20.4 ASTELLAS PHARMA Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.20.5 ASTELLAS PHARMA Recent Development
11.21 TEVA PHARMACEUTICAL INDUSTRIES
11.21.1 TEVA PHARMACEUTICAL INDUSTRIES Company Details
11.21.2 TEVA PHARMACEUTICAL INDUSTRIES Business Overview
11.21.3 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R & D Introduction
11.21.4 TEVA PHARMACEUTICAL INDUSTRIES Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
11.21.5 TEVA PHARMACEUTICAL INDUSTRIES Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Roche
Johnson & Johnson
Merck
Novartis
Pfizer Inc
Sanofi
Bayer
Bristol–Myers Squibb
Astrazeneca plc
GlaxoSmithKline PLC
AbbVie
Eli Lilly
BOEHRINGER SOHN
Amgen Inc
Gilead Sciences
Takeda Pharmaceutical
Novo Nordisk
Biogen
Abbott
Astellas Pharma
Teva Pharmaceutical Industries
List of Tables
 Table 1. Global Pharmaceuticals and Biotechnology R & D Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Drug
 Table 3. Key Players of Medical Equipment
 Table 4. Key Players of Vaccine
 Table 5. Key Players of Others
 Table 6. Global Pharmaceuticals and Biotechnology R & D Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Pharmaceuticals and Biotechnology R & D Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Pharmaceuticals and Biotechnology R & D Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Pharmaceuticals and Biotechnology R & D Market Share by Region (2020-2025)
 Table 10. Global Pharmaceuticals and Biotechnology R & D Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Pharmaceuticals and Biotechnology R & D Market Share by Region (2026-2031)
 Table 12. Pharmaceuticals and Biotechnology R & D Market Trends
 Table 13. Pharmaceuticals and Biotechnology R & D Market Drivers
 Table 14. Pharmaceuticals and Biotechnology R & D Market Challenges
 Table 15. Pharmaceuticals and Biotechnology R & D Market Restraints
 Table 16. Global Pharmaceuticals and Biotechnology R & D Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Pharmaceuticals and Biotechnology R & D Market Share by Players (2020-2025)
 Table 18. Global Top Pharmaceuticals and Biotechnology R & D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceuticals and Biotechnology R & D as of 2024)
 Table 19. Ranking of Global Top Pharmaceuticals and Biotechnology R & D Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Pharmaceuticals and Biotechnology R & D Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Pharmaceuticals and Biotechnology R & D, Headquarters and Area Served
 Table 22. Global Key Players of Pharmaceuticals and Biotechnology R & D, Product and Application
 Table 23. Global Key Players of Pharmaceuticals and Biotechnology R & D, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Pharmaceuticals and Biotechnology R & D Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Pharmaceuticals and Biotechnology R & D Revenue Market Share by Type (2020-2025)
 Table 27. Global Pharmaceuticals and Biotechnology R & D Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Pharmaceuticals and Biotechnology R & D Revenue Market Share by Type (2026-2031)
 Table 29. Global Pharmaceuticals and Biotechnology R & D Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Pharmaceuticals and Biotechnology R & D Revenue Market Share by Application (2020-2025)
 Table 31. Global Pharmaceuticals and Biotechnology R & D Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Pharmaceuticals and Biotechnology R & D Revenue Market Share by Application (2026-2031)
 Table 33. North America Pharmaceuticals and Biotechnology R & D Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Pharmaceuticals and Biotechnology R & D Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Pharmaceuticals and Biotechnology R & D Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Pharmaceuticals and Biotechnology R & D Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Pharmaceuticals and Biotechnology R & D Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Pharmaceuticals and Biotechnology R & D Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Pharmaceuticals and Biotechnology R & D Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Pharmaceuticals and Biotechnology R & D Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pharmaceuticals and Biotechnology R & D Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Size by Country (2026-2031) & (US$ Million)
 Table 48. ROCHE Company Details
 Table 49. ROCHE Business Overview
 Table 50. ROCHE Pharmaceuticals and Biotechnology R & D Product
 Table 51. ROCHE Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 52. ROCHE Recent Development
 Table 53. JOHNSON & JOHNSON Company Details
 Table 54. JOHNSON & JOHNSON Business Overview
 Table 55. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R & D Product
 Table 56. JOHNSON & JOHNSON Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 57. JOHNSON & JOHNSON Recent Development
 Table 58. MERCK Company Details
 Table 59. MERCK Business Overview
 Table 60. MERCK Pharmaceuticals and Biotechnology R & D Product
 Table 61. MERCK Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 62. MERCK Recent Development
 Table 63. NOVARTIS Company Details
 Table 64. NOVARTIS Business Overview
 Table 65. NOVARTIS Pharmaceuticals and Biotechnology R & D Product
 Table 66. NOVARTIS Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 67. NOVARTIS Recent Development
 Table 68. PFIZER Company Details
 Table 69. PFIZER Business Overview
 Table 70. PFIZER Pharmaceuticals and Biotechnology R & D Product
 Table 71. PFIZER Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 72. PFIZER Recent Development
 Table 73. SANOFI Company Details
 Table 74. SANOFI Business Overview
 Table 75. SANOFI Pharmaceuticals and Biotechnology R & D Product
 Table 76. SANOFI Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 77. SANOFI Recent Development
 Table 78. BAYER Company Details
 Table 79. BAYER Business Overview
 Table 80. BAYER Pharmaceuticals and Biotechnology R & D Product
 Table 81. BAYER Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 82. BAYER Recent Development
 Table 83. BRISTOL-MYERS SQUIBB Company Details
 Table 84. BRISTOL-MYERS SQUIBB Business Overview
 Table 85. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R & D Product
 Table 86. BRISTOL-MYERS SQUIBB Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 87. BRISTOL-MYERS SQUIBB Recent Development
 Table 88. ASTRAZENECA Company Details
 Table 89. ASTRAZENECA Business Overview
 Table 90. ASTRAZENECA Pharmaceuticals and Biotechnology R & D Product
 Table 91. ASTRAZENECA Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 92. ASTRAZENECA Recent Development
 Table 93. GLAXOSMITHKLINE Company Details
 Table 94. GLAXOSMITHKLINE Business Overview
 Table 95. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R & D Product
 Table 96. GLAXOSMITHKLINE Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 97. GLAXOSMITHKLINE Recent Development
 Table 98. ABBVIE Company Details
 Table 99. ABBVIE Business Overview
 Table 100. ABBVIE Pharmaceuticals and Biotechnology R & D Product
 Table 101. ABBVIE Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 102. ABBVIE Recent Development
 Table 103. ELI LILLY Company Details
 Table 104. ELI LILLY Business Overview
 Table 105. ELI LILLY Pharmaceuticals and Biotechnology R & D Product
 Table 106. ELI LILLY Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 107. ELI LILLY Recent Development
 Table 108. BOEHRINGER SOHN Company Details
 Table 109. BOEHRINGER SOHN Business Overview
 Table 110. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R & D Product
 Table 111. BOEHRINGER SOHN Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 112. BOEHRINGER SOHN Recent Development
 Table 113. AMGEN Company Details
 Table 114. AMGEN Business Overview
 Table 115. AMGEN Pharmaceuticals and Biotechnology R & D Product
 Table 116. AMGEN Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 117. AMGEN Recent Development
 Table 118. GILEAD SCIENCES Company Details
 Table 119. GILEAD SCIENCES Business Overview
 Table 120. GILEAD SCIENCES Pharmaceuticals and Biotechnology R & D Product
 Table 121. GILEAD SCIENCES Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 122. GILEAD SCIENCES Recent Development
 Table 123. TAKEDA PHARMACEUTICAL Company Details
 Table 124. TAKEDA PHARMACEUTICAL Business Overview
 Table 125. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R & D Product
 Table 126. TAKEDA PHARMACEUTICAL Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 127. TAKEDA PHARMACEUTICAL Recent Development
 Table 128. NOVO NORDISK Company Details
 Table 129. NOVO NORDISK Business Overview
 Table 130. NOVO NORDISK Pharmaceuticals and Biotechnology R & D Product
 Table 131. NOVO NORDISK Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 132. NOVO NORDISK Recent Development
 Table 133. BIOGEN Company Details
 Table 134. BIOGEN Business Overview
 Table 135. BIOGEN Pharmaceuticals and Biotechnology R & D Product
 Table 136. BIOGEN Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 137. BIOGEN Recent Development
 Table 138. ABBOTT Company Details
 Table 139. ABBOTT Business Overview
 Table 140. ABBOTT Pharmaceuticals and Biotechnology R & D Product
 Table 141. ABBOTT Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 142. ABBOTT Recent Development
 Table 143. ASTELLAS PHARMA Company Details
 Table 144. ASTELLAS PHARMA Business Overview
 Table 145. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R & D Product
 Table 146. ASTELLAS PHARMA Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 147. ASTELLAS PHARMA Recent Development
 Table 148. TEVA PHARMACEUTICAL INDUSTRIES Company Details
 Table 149. TEVA PHARMACEUTICAL INDUSTRIES Business Overview
 Table 150. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R & D Product
 Table 151. TEVA PHARMACEUTICAL INDUSTRIES Revenue in Pharmaceuticals and Biotechnology R & D Business (2020-2025) & (US$ Million)
 Table 152. TEVA PHARMACEUTICAL INDUSTRIES Recent Development
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Pharmaceuticals and Biotechnology R & D Picture
 Figure 2. Global Pharmaceuticals and Biotechnology R & D Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmaceuticals and Biotechnology R & D Market Share by Type: 2024 VS 2031
 Figure 4. Drug Features
 Figure 5. Medical Equipment Features
 Figure 6. Vaccine Features
 Figure 7. Others Features
 Figure 8. Global Pharmaceuticals and Biotechnology R & D Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Pharmaceuticals and Biotechnology R & D Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Case Studies
 Figure 11. Clinic Case Studies
 Figure 12. Homecare Case Studies
 Figure 13. Others Case Studies
 Figure 14. Pharmaceuticals and Biotechnology R & D Report Years Considered
 Figure 15. Global Pharmaceuticals and Biotechnology R & D Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Pharmaceuticals and Biotechnology R & D Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Pharmaceuticals and Biotechnology R & D Market Share by Region: 2024 VS 2031
 Figure 18. Global Pharmaceuticals and Biotechnology R & D Market Share by Players in 2024
 Figure 19. Global Top Pharmaceuticals and Biotechnology R & D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceuticals and Biotechnology R & D as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Pharmaceuticals and Biotechnology R & D Revenue in 2024
 Figure 21. North America Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Pharmaceuticals and Biotechnology R & D Market Share by Country (2020-2031)
 Figure 23. United States Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Pharmaceuticals and Biotechnology R & D Market Share by Country (2020-2031)
 Figure 27. Germany Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Share by Region (2020-2031)
 Figure 35. China Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Pharmaceuticals and Biotechnology R & D Market Share by Country (2020-2031)
 Figure 43. Mexico Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Share by Country (2020-2031)
 Figure 47. Turkey Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. ROCHE Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 51. JOHNSON & JOHNSON Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 52. MERCK Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 53. NOVARTIS Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 54. PFIZER Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 55. SANOFI Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 56. BAYER Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 57. BRISTOL-MYERS SQUIBB Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 58. ASTRAZENECA Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 59. GLAXOSMITHKLINE Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 60. ABBVIE Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 61. ELI LILLY Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 62. BOEHRINGER SOHN Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 63. AMGEN Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 64. GILEAD SCIENCES Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 65. TAKEDA PHARMACEUTICAL Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 66. NOVO NORDISK Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 67. BIOGEN Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 68. ABBOTT Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 69. ASTELLAS PHARMA Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 70. TEVA PHARMACEUTICAL INDUSTRIES Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2020-2025)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

New Drug Research and Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Clinical Trials of Drugs and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biotherapeutics Cell Line Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biopharma Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vitro Diagnostics Reagents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biosimilars Follow on Biologics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Guidewire Market Research Report 2024
Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Computer Vision in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Still s Disease Treatment Market Research Report 2025
Pharmacogenomics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Asset Managements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Generic and Biosimilar Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions